Skip to main content
. 2024 Oct 28;12(11):1224. doi: 10.3390/vaccines12111224

Table 2.

Seroprotection rate of pre-vaccination HI titers for the four antigens, depending on the type of conditioning chemotherapy regimen in the HSCT group.

No. of Cases (%)
Myeloablative
(n = 22)
Reduced Intensity
(n = 5)
p
A/H1N1 10 (45.5) 5 (100) 0.027
A/H3N2 13 (59.1) 5 (100) 0.080
B/Victoria 2 (9.1) 0 (0) 0.484
B/Yamagata 5 (22.7) 0 (0) 0.238